Durvalumab as Maintenance in Patients who Received Chemoradiotherapy for Unresectable Stage III NSCLC: RWD from an EAP in Brazil (LACOG 0120)

被引：0

作者：

Zukin, M. ^{[1
]}

Gelatti, A. C. Z. ^{[2
]}

Gondim, V. ^{[3
]}

Shimada, A. K. ^{[4
]}

Magalhaes, E. ^{[5
]}

Mathias, C. ^{[6
]}

Barra, W. F. ^{[7
]}

William Junior, W. N. ^{[8
]}

Padoan, M. ^{[3
]}

Bittencourt, Y. ^{[4
]}

Yamamura, R. ^{[8
]}

Gossling, G. ^{[9
]}

Rebelatto, T. F. ^{[9
]}

de Jesus, R. G. ^{[9
]}

Silva, C. E. B. ^{[10
]}

机构：

[1] Oncol & Inst, Sao Paulo, Brazil

[2] CPO Porto Alegre, Porto Alegre, RS, Brazil

[3] Inst Amer, Rio De Janeiro, Brazil

[4] Hosp Sirio Libanes, Sao Paulo, SP, Brazil

[5] Inst Mario Penna, Belo Horizonte, MG, Brazil

[6] Oncoclin BA & Hosp Santa Izabel, Salvador, BA, Brazil

[7] Univ Fed Nucl Pesquisa Oncol, Belem, Para, Brazil

[8] BP A Beneficencia Portuguesa Sao Paulo, Sao Paulo, SP, Brazil

[9] Latin Amer Cooperat Oncol Grp LACOG, Porto Alegre, RS, Brazil

[10] Hosp Canc Barretos, Barretos, Brazil

来源：

关键词：

Non-Small Cell Lung Cancer; Durvalumab; Brazil;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EP08.02-30

引用

页码：S582 / S582

页数：1